Liquidia Corp.
(NASDAQ : LQDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.23%177.110.7%$1337.30m
MRKMerck & Co., Inc. -0.30%90.900.7%$1164.37m
PFEPfizer Inc. -1.33%51.740.9%$1099.03m
LLYEli Lilly & Co. -1.33%319.931.1%$1031.80m
BMYBristol-Myers Squibb Co. -1.32%75.991.0%$994.64m
ABBVAbbVie, Inc. -0.65%152.171.9%$952.53m
AZNAstraZeneca Plc -1.23%65.261.0%$436.07m
SGENSeagen Inc. 1.39%179.405.7%$320.28m
TPTXTurning Point Therapeutics, Inc. -0.11%75.170.0%$287.77m
GSKGSK Plc -0.39%43.360.2%$275.37m
NVSNovartis AG -1.08%83.620.2%$162.80m
HZNPHorizon Therapeutics Plc 0.53%80.185.4%$162.66m
MRTXMirati Therapeutics, Inc. 5.44%70.781.6%$154.68m
ALNYAlnylam Pharmaceuticals, Inc. 1.75%148.408.1%$142.97m
NVONovo Nordisk A/S -0.79%110.550.1%$142.09m

Company Profile

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company was founded on June 28, 2020 and is headquartered in Morrisville, NC.